Literature DB >> 3240722

A new selective antagonist of vascular serotonin receptors lowers blood pressure in spontaneously hypertensive rats.

P Salvati1, F Vaghi, M Colombo, G Bianchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3240722     DOI： 10.2165/00003495-198800361-00019

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. II. Competitive antagonists.

Authors:  D R Waud; R B Parker
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

2.  Mechanism of the hypotensive effect of ketanserin.

Authors:  J R Fozard
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

3.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

4.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

5.  The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension.

Authors:  J De Crée; J Leempoels; H Geukens; W De Cock; H Verhaegen
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.